These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 30073930)
21. Carfilzomib Is Not an Appropriate Payload of Antibody-Drug Conjugates Due to Rapid Inactivation by Lysosomal Enzymes. Ma Y; Dela Cruz-Chuh J; Khojasteh SC; Dragovich PS; Pillow TH; Zhang D Drug Metab Dispos; 2019 Aug; 47(8):884-889. PubMed ID: 31072822 [TBL] [Abstract][Full Text] [Related]
22. Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies. Almhanna K; Prithviraj GK; Veiby P; Kalebic T Pharmacol Ther; 2017 Feb; 170():8-13. PubMed ID: 27765652 [TBL] [Abstract][Full Text] [Related]
23. Linkers Having a Crucial Role in Antibody-Drug Conjugates. Lu J; Jiang F; Lu A; Zhang G Int J Mol Sci; 2016 Apr; 17(4):561. PubMed ID: 27089329 [TBL] [Abstract][Full Text] [Related]
24. Cleavable linkers in antibody-drug conjugates. Bargh JD; Isidro-Llobet A; Parker JS; Spring DR Chem Soc Rev; 2019 Aug; 48(16):4361-4374. PubMed ID: 31294429 [TBL] [Abstract][Full Text] [Related]
25. Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Abdollahpour-Alitappeh M; Lotfinia M; Gharibi T; Mardaneh J; Farhadihosseinabadi B; Larki P; Faghfourian B; Sepehr KS; Abbaszadeh-Goudarzi K; Abbaszadeh-Goudarzi G; Johari B; Zali MR; Bagheri N J Cell Physiol; 2019 May; 234(5):5628-5642. PubMed ID: 30478951 [TBL] [Abstract][Full Text] [Related]
26. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment. Edupuganti VVSR; Tyndall JDATDA; Gamble AB Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624 [TBL] [Abstract][Full Text] [Related]
27. Recent Advances in Antibody Drug Conjugates for Lymphoma. Russler-Germain DA; Kahl BS Oncology (Williston Park); 2020 Dec; 34(12):522-534. PubMed ID: 33395492 [TBL] [Abstract][Full Text] [Related]
28. Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates. Pabst M; McDowell W; Manin A; Kyle A; Camper N; De Juan E; Parekh V; Rudge F; Makwana H; Kantner T; Parekh H; Michelet A; Sheng X; Popa G; Tucker C; Khayrzad F; Pollard D; Kozakowska K; Resende R; Jenkins A; Simoes F; Morris D; Williams P; Badescu G; Baker MP; Bird M; Frigerio M; Godwin A J Control Release; 2017 May; 253():160-164. PubMed ID: 28257988 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy. Tong XM; Feng L; Suthe SR; Weng TH; Hu CY; Liu YZ; Wu ZG; Wang MH; Yao HP J Immunother Cancer; 2019 Sep; 7(1):250. PubMed ID: 31519211 [TBL] [Abstract][Full Text] [Related]
30. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry. Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414 [TBL] [Abstract][Full Text] [Related]
31. Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. Lhospice F; Brégeon D; Belmant C; Dennler P; Chiotellis A; Fischer E; Gauthier L; Boëdec A; Rispaud H; Savard-Chambard S; Represa A; Schneider N; Paturel C; Sapet M; Delcambre C; Ingoure S; Viaud N; Bonnafous C; Schibli R; Romagné F Mol Pharm; 2015 Jun; 12(6):1863-71. PubMed ID: 25625323 [TBL] [Abstract][Full Text] [Related]
32. Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody-Drug Conjugates. Nadkarni DV; Lee J; Jiang Q; Patel V; Sriskanda V; Dutta K; Meyer DM Mol Pharm; 2021 Mar; 18(3):889-897. PubMed ID: 33470823 [TBL] [Abstract][Full Text] [Related]